#NewAseBioMember “AseBio for us, it is the strategic meeting point where biotechnology connects with the challenges of the agri‑food sector”

AseBio. What does your company's work bring to the table and what is its strength?

Carlos Rodríguez-Villa Förster. At Phoenix Biosolutions, we specialize in accelerating the deployment of advanced biotechnological solutions in the field through a TaaS (Technology as a Service) model. Our approach goes beyond commercializing products: we empower regional distributors by transferring the technology, know‑how, and protocols they need to produce their own next‑generation biostimulants - more bioactive, fresher, and adapted to the needs of each market.

By decentralizing production, we significantly shorten the distribution chain of high value‑added products. This architecture allows our partners to gain autonomy, protect their commercial strategy, reduce logistics costs, and avoid unnecessary intermediaries, while maintaining the highest standards of quality, sustainability, and traceability.

The main beneficiary is the farmer: they gain access to cutting‑edge innovation more directly, more efficiently, and at a more competitive cost thanks to the elimination of layers inherent to the traditional agricultural distribution model. This accelerates the adoption of biotechnology in the field and democratizes its access.

AseBio. What does AseBio mean to you?

Carlos Rodríguez-Villa Förster. For us, it is the strategic meeting point where biotechnology connects with the challenges of the agri‑food sector. It is the platform that unites the companies that, like ours, believe that the future of agriculture relies on science and rigor. It is the voice that defends Spanish innovation and the ideal forum to promote policies that support a circular bioeconomy in the field.

AseBio. When did you first hear about AseBio?

Carlos Rodríguez-Villa Förster. We have known about AseBio’s work since our early days in the sector. It has always been the key reference for understanding the evolution of the biosciences in Spain and the essential ally for any company seeking to transform research into tangible agricultural solutions.

AseBio. What do you expect from being part of an association like AseBio?

Carlos Rodríguez-Villa Förster. We hope to strengthen our network of alliances to continue driving technological transfer in the agricultural sector. We want to actively contribute to knowledge generation and to the professionalization of biostimulants, collaborating in working groups that accelerate their market introduction and improve regulatory frameworks.

Furthermore, as we chair EBIC (European Biostimulant Industry Council), likely the most relevant agribiological association in the world, we would like to explore ways to build close collaboration between both institutions—aligning national efforts with the European strategy and ensuring biotechnology becomes a driver of competitiveness in agriculture.

AseBio. What is the biggest challenge for the biotech sector or for your company?

Carlos Rodríguez-Villa Förster. Historically, high‑end biostimulant technology has been a luxury. Centralized manufacturing, logistics, and intermediary margins created an insurmountable barrier: innovation reached the field, but at a price that undermined the farmer’s profitability. At Phoenix Biosolutions, our challenge is to break this technological “glass ceiling.”

Through our TaaS (Technology as a Service) model, we eliminate inefficient transportation and distribution costs. By enabling regional distributors to produce locally using our technology, we drastically reduce the final price. This ensures that cutting‑edge solutions—previously limited to niche markets—are now accessible and profitable for any crop and scale.

Our goal is to return biotechnological sovereignty to the distribution channel and competitiveness to the farmer. We want to demonstrate that innovation is not an added cost, but the most effective tool to improve field performance. Biotechnology is truly transformative only when every producer can access it—without price ever becoming an obstacle.